1. Sun, Haoting, Wang, Chaoqun, Hu, Beiyuan, Dong, Qiongzhu, Qin, Lunxiu. 2021. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3. In Signal transduction and targeted therapy, 6, 187. doi:10.1038/s41392-021-00579-3. https://pubmed.ncbi.nlm.nih.gov/34035222/
2. Denton, Christopher P, Xu, Shiwen, Zhang, Fenge, Hallén, Jonas, Ong, Voon H. 2023. Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis. In Annals of the rheumatic diseases, 82, 1205-1217. doi:10.1136/ard-2023-223862. https://pubmed.ncbi.nlm.nih.gov/37414521/
3. Cheng, Gumeng, Tian, Kailin, Zhang, Lu, Xing, Yiqiao, He, Tao. 2015. S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression. In Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 254, 97-108. doi:10.1007/s00417-015-3158-0. https://pubmed.ncbi.nlm.nih.gov/26358273/
4. Shi, Jiajun, Yu, Wenjun, Liang, Chuan, Dong, Zhe, Liu, Jinping. 2024. S100A4 Is a Key Facilitator of Thoracic Aortic Dissection. In International journal of biological sciences, 20, 29-46. doi:10.7150/ijbs.83091. https://pubmed.ncbi.nlm.nih.gov/38164183/